Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Locally Advanced or Metastatic Breast Cancer
Interventions: DRUG: Eribulin
Sponsor: Eisai GmbH